Latest filings (excl ownership)
No filings
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
15 May 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G
Celldex Therapeutics, Inc.
13 Feb 24
SC 13G
AVADEL PHARMACEUTICALS PLC
13 Feb 24
SC 13G/A
Spyre Therapeutics, Inc.
13 Feb 24
SC 13G/A
Revance Therapeutics, Inc.
13 Feb 24
SC 13G/A
NanoString Technologies Inc
13 Feb 24
SC 13G/A
Arcutis Biotherapeutics, Inc.
13 Feb 24
13F-HR/A
Quarterly holdings report by institutional manager (amended)
13 Dec 23
13F-HR/A
Quarterly holdings report by institutional manager (amended)
13 Dec 23
13F-HR/A
Quarterly holdings report by institutional manager (amended)
22 Nov 23
SC 13G
Arcutis Biotherapeutics, Inc.
16 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13G
Aeglea BioTherapeutics, Inc.
28 Jul 23
SC 13G/A
NanoString Technologies Inc
13 Jul 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
SC 13G/A
Summit Therapeutics Inc.
14 Feb 23
SC 13G/A
Quotient Ltd
14 Feb 23
SC 13G
NanoString Technologies Inc
14 Feb 23
SC 13G/A
INFINITY PHARMACEUTICALS, INC.
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
SC 13G
Revance Therapeutics, Inc.
14 Feb 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 22
13F-HR
Quarterly holdings report by institutional manager
15 Aug 22
13F-HR
Quarterly holdings report by institutional manager
16 May 22
SC 13G/A
BELLUS Health Inc.
14 Feb 22
SC 13G/A
Summit Therapeutics Inc.
14 Feb 22
SC 13G/A
Quotient Ltd
14 Feb 22
SC 13G/A
Oxford Immunotec Global PLC
14 Feb 22
SC 13G
INFINITY PHARMACEUTICALS, INC.
14 Feb 22
SC 13G/A
AVADEL PHARMACEUTICALS PLC
14 Feb 22
13F-HR
Quarterly holdings report by institutional manager
14 Feb 22
13F-HR
Quarterly holdings report by institutional manager
15 Nov 21
13F-HR
Quarterly holdings report by institutional manager
16 Aug 21
13F-HR
Quarterly holdings report by institutional manager
17 May 21
13F-HR
Quarterly holdings report by institutional manager
16 Feb 21
SC 13G
AVADEL PHARMACEUTICALS PLC
16 Feb 21
SC 13G
Summit Therapeutics Inc.
16 Feb 21
SC 13G/A
Oxford Immunotec Global PLC
16 Feb 21